Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX.
- DOI
- 10.1136/ard-2024-225640
- Published
- 2024 Sep 30
- Container
- Annals of the rheumatic diseases
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/ard-2024-225640,
title = {Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX.},
author = {Hadjadj J and Nguyen Y and Mouloudj D and Bourguiba R and Heiblig M and Aloui H and McAvoy C and Lacombe V and Ardois S and Campochiaro C and Maria A and Coustal C and Comont T and Lazaro E and Lifermann F and Le Guenno G and Lobbes H and Grobost V and Outh R and Campagne J and Dor-Etienne A and Garnier A and Jamilloux Y and Dossier A and Samson M and Audia S and Nicolas B and Mathian A and de Maleprade B and De Sainte-Marie B and Faucher B and Bouaziz JD and Broner J and Dumain C and Antoine C and Carpentier B and Castel B and Lartigau-Roussin C and Crickx E and Volle G and Fayard D and Decker P and Moulinet T and Dumont A and Nguyen A and Aouba A and Martellosio JP and Levavasseur M and Puigrenier S and Antoine P and Giraud JT and Hermine O and Lacout C and Martis N and Karam JD and Chasset F and Arnaud L and Marianetti P and Deligny C and Chazal T and Woaye-Hune P and Roux-Sauvat M and Meyer A and Sujobert P and Hirsch P and Abisror N and Fenaux P and Kosmider O and Jachiet V and Fain O and Terrier B and Mekinian A and Georgin-Lavialle S and FRENVEX},
year = {2024},
journal = {Annals of the rheumatic diseases},
doi = {10.1136/ard-2024-225640},
url = {https://doi.org/10.1136/ard-2024-225640}
}RIS
TY - JOUR TI - Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX. AU - Hadjadj J AU - Nguyen Y AU - Mouloudj D AU - Bourguiba R AU - Heiblig M AU - Aloui H AU - McAvoy C AU - Lacombe V AU - Ardois S AU - Campochiaro C AU - Maria A AU - Coustal C AU - Comont T AU - Lazaro E AU - Lifermann F AU - Le Guenno G AU - Lobbes H AU - Grobost V AU - Outh R AU - Campagne J AU - Dor-Etienne A AU - Garnier A AU - Jamilloux Y AU - Dossier A AU - Samson M AU - Audia S AU - Nicolas B AU - Mathian A AU - de Maleprade B AU - De Sainte-Marie B AU - Faucher B AU - Bouaziz JD AU - Broner J AU - Dumain C AU - Antoine C AU - Carpentier B AU - Castel B AU - Lartigau-Roussin C AU - Crickx E AU - Volle G AU - Fayard D AU - Decker P AU - Moulinet T AU - Dumont A AU - Nguyen A AU - Aouba A AU - Martellosio JP AU - Levavasseur M AU - Puigrenier S AU - Antoine P AU - Giraud JT AU - Hermine O AU - Lacout C AU - Martis N AU - Karam JD AU - Chasset F AU - Arnaud L AU - Marianetti P AU - Deligny C AU - Chazal T AU - Woaye-Hune P AU - Roux-Sauvat M AU - Meyer A AU - Sujobert P AU - Hirsch P AU - Abisror N AU - Fenaux P AU - Kosmider O AU - Jachiet V AU - Fain O AU - Terrier B AU - Mekinian A AU - Georgin-Lavialle S AU - FRENVEX PY - 2024 JO - Annals of the rheumatic diseases DO - 10.1136/ard-2024-225640 UR - https://doi.org/10.1136/ard-2024-225640 ER -
APA
J, H., Y, N., D, M., R, B., M, H., H, A., C, M., V, L., S, A., C, C., A, M., C, C., T, C., E, L., F, L., G, L. G., H, L., V, G., R, O., J, C., A, D., A, G., Y, J., A, D., M, S., S, A., B, N., A, M., B, D. M., B, D. S., B, F., JD, B., J, B., C, D., C, A., B, C., B, C., C, L., E, C., G, V., D, F., P, D., T, M., A, D., A, N., A, A., JP, M., M, L., S, P., P, A., JT, G., O, H., C, L., N, M., JD, K., F, C., L, A., P, M., C, D., T, C., P, W., M, R., A, M., P, S., P, H., N, A., P, F., O, K., V, J., O, F., B, T., A, M., S, G., & FRENVEX (2024). Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX.. Annals of the rheumatic diseases. https://doi.org/10.1136/ard-2024-225640
Source records
- pubmed · retrieved 2026-09-26T08:34:35.307Z